VF
CORT icon

Virtu Financial’s Corcept Therapeutics CORT Stock Holding History

Virtu Financial’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,099
Closed -$456K – 1725
2025
Q4 		$456K Buy
+13,099
New +$1.03M 0.02% 647
2023
Q4 		– Sell
-8,324
Closed -$227K – 1629
2023
Q3 		$227K Buy
+8,324
New +$241K 0.02% 613
2019
Q4 		$269K Buy
+22,205
New +$309K 0.03% 748
2019
Q1 		– Sell
-13,647
Closed -$182K – 1462
2018
Q4 		$182K Buy
+13,647
New +$180K 0.01% 997
2018
Q3 		– Sell
-10,620
Closed -$167K – 1616
2018
Q2 		$167K Sell
10,620
-1,936
-15% -$33.7K 0.01% 1553
2018
Q1 		$207K Buy
+12,556
New +$233K 0.01% 1337

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Virtu Financial's CORT Position: Q1 2026 in Review

Virtu Financial sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 13,099 shares — an estimated $456K sold.

Virtu Financial first reported a position in CORT in Q1 2018 and held it in 6 quarters. The position peaked at $456K in Q4 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Virtu Financial reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 13,099 Corcept Therapeutics shares in Q1 2026, an estimated $456K.
  • Virtu Financial first reported a position in Corcept Therapeutics in Q1 2018 and held it in 6 quarters.
  • Virtu Financial's Corcept Therapeutics position peaked at $456K in Q4 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.